Bioversys AG Net Asset Quality Index
Bioversys AG net asset quality index. Bioversys AG (BIOV) has a Net Asset Quality Index of 58.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CHF76.91 Million minus total liabilities of CHF32.07 Million yields net assets of CHF44.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. See BIOV book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Bioversys AG (2024–2025)
Net asset quality index of Bioversys AG from 2024 to 2025. This chart shows how Bioversys AG's Net Asset Quality Index has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the index stands at 58.3%, representing net assets of CHF44.84 Million against total assets of CHF76.91 Million CHF. Check tangible equity quality of Bioversys AG to evaluate the tangible quality of the company's equity base.
Bioversys AG Net Asset Quality Index by Year (2024–2025)
Bioversys AG net asset quality index by year from 2024 to 2025. The table below presents the year-by-year Net Asset Quality Index for Bioversys AG from 2024 to 2025, covering 2 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BIOV market cap.
| Year | Quality Index | Net Assets (CHF) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.0% | CHF59.81 Million | CHF90.64 Million | CHF30.82 Million | ▲ +35.4 pp |
| 2024 | 30.6% | CHF10.68 Million | CHF34.96 Million | CHF24.27 Million | — |